Skip Nav Destination
Safety, Outcomes, and T-Cell Characteristics in Patients with Relapsed or Refractory MDS or CMML Treated with Atezolizumab in Combination with Guadecitabine
Clin Cancer Res (2022) 28 (24): 5306–5316.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
- Claudia Galassi
- Manel Esteller
- Ilio Vitale
- Lorenzo Galluzzi
Trends in Cancer (2024)
- Mary M. Czech
- Eduard Schulz
- Alain Mina
- Juan Gea-Banacloche
Seminars in Hematology (2024)
- Anupam Verma
- Yueh-Yun Chi
- Jemily Malvar
- Adam Lamble
- Sonali Chaudhury
- Archana Agarwal
- Hong-Tao Li
- Gangning Liang
- Roy Leong
- Patrick A. Brown
- Joel Kaplan
- Eric S. Schafer
- Tamra Slone
- Melinda Pauly
- Bill H. Chang
- Elliot Stieglitz
- Alan S. Wayne
- Nobuko Hijiya
- Deepa Bhojwani
Cancers (2024) 16 (3): 496.
- Xi-Chen Zhao
- Bo Ju
- Nuan-Nuan Xiu
- Xiao-Yun Sun
- Fan-Jun Meng
Frontiers in Immunology (2024) 15
- Hanghang Zhang
- Chen Huang
- John Gordon
- Sijia Yu
- George Morton
- Wayne Childers
- Magid Abou-Gharbia
- Yi Zhang
- Jaroslav Jelinek
- Jean-Pierre J. Issa
Clinical Epigenetics (2024) 16 (1)
- Huizhen Cao
- Tianyu Wu
- Xue Zhou
- Shuyang Xie
- Hongfang Sun
- Yunxiao Sun
- Youjie Li
Frontiers in Immunology (2023) 14
RSS Feeds